BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27928627)

  • 1. Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment.
    Farmahin R; Williams A; Kuo B; Chepelev NL; Thomas RS; Barton-Maclaren TS; Curran IH; Nong A; Wade MG; Yauk CL
    Arch Toxicol; 2017 May; 91(5):2045-2065. PubMed ID: 27928627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
    Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
    PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal concordance between apical and transcriptional points of departure for chemical risk assessment.
    Thomas RS; Wesselkamper SC; Wang NC; Zhao QJ; Petersen DD; Lambert JC; Cote I; Yang L; Healy E; Black MB; Clewell HJ; Allen BC; Andersen ME
    Toxicol Sci; 2013 Jul; 134(1):180-94. PubMed ID: 23596260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes.
    Labib S; Williams A; Yauk CL; Nikota JK; Wallin H; Vogel U; Halappanavar S
    Part Fibre Toxicol; 2016 Mar; 13():15. PubMed ID: 26979667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide.
    LaRocca J; Costa E; Sriram S; Hannas BR; Johnson KJ
    Regul Toxicol Pharmacol; 2020 Jun; 113():104655. PubMed ID: 32268158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMDExpress Data Viewer - a visualization tool to analyze BMDExpress datasets.
    Kuo B; Francina Webster A; Thomas RS; Yauk CL
    J Appl Toxicol; 2016 Aug; 36(8):1048-59. PubMed ID: 26671443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microRNA or messenger RNA point of departure estimates an apical endpoint point of departure in a rat developmental toxicity model.
    Johnson KJ; Costa E; Marshall V; Sriram S; Venkatraman A; Stebbins K; LaRocca J
    Birth Defects Res; 2022 Jul; 114(11):559-576. PubMed ID: 35596682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rat Liver Transcriptomic Point of Departure Predicts a Prospective Liver or Non-liver Apical Point of Departure.
    Johnson KJ; Auerbach SS; Costa E
    Toxicol Sci; 2020 Jul; 176(1):86-102. PubMed ID: 32384157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic transcriptional dose-response analysis of male and female Fischer rats exposed to hexabromocyclododecane.
    Farmahin R; Gannon AM; Gagné R; Rowan-Carroll A; Kuo B; Williams A; Curran I; Yauk CL
    Food Chem Toxicol; 2019 Nov; 133():110262. PubMed ID: 30594549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.
    Izadi H; Grundy JE; Bose R
    Risk Anal; 2012 May; 32(5):830-5. PubMed ID: 22126138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editor's Highlight: Application of Gene Set Enrichment Analysis for Identification of Chemically Induced, Biologically Relevant Transcriptomic Networks and Potential Utilization in Human Health Risk Assessment.
    Dean JL; Zhao QJ; Lambert JC; Hawkins BS; Thomas RS; Wesselkamper SC
    Toxicol Sci; 2017 May; 157(1):85-99. PubMed ID: 28123101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rat subchronic study transcriptional point of departure estimates a carcinogenicity study apical point of departure.
    Bianchi E; Costa E; Yan ZJ; Murphy L; Howell J; Anderson D; Mukerji P; Venkatraman A; Terry C; Johnson KJ
    Food Chem Toxicol; 2021 Jan; 147():111869. PubMed ID: 33217531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of microarrays and RNA-seq for gene expression analyses of dose-response experiments.
    Black MB; Parks BB; Pluta L; Chu TM; Allen BC; Wolfinger RD; Thomas RS
    Toxicol Sci; 2014 Feb; 137(2):385-403. PubMed ID: 24194394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic points-of-departure from short-term exposure studies are protective of chronic effects for fish exposed to estrogenic chemicals.
    Pagé-Larivière F; Crump D; O'Brien JM
    Toxicol Appl Pharmacol; 2019 Sep; 378():114634. PubMed ID: 31226361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional benchmark dose modeling: Exploring how advances in chemical risk assessment may be applied to the radiation field.
    Chauhan V; Kuo B; McNamee JP; Wilkins RC; Yauk CL
    Environ Mol Mutagen; 2016 Oct; 57(8):589-604. PubMed ID: 27601323
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.